Mol Cell Endocrinol (2016) 436:2409
The peptide appears to act antagonistically on opiate receptors, significantly inhibiting the development of both opioid and alcohol dependence in animal studies
Jnsson T, Granfeldt Y, Ahrn B, Branell UC, Plsson G, Hansson A, Sderstrm M, Lindeberg S
Most importantly, the limited amount of albumin leading to competition between icodec and semaglutide for albumin binding sites is only a local phenomenon occurring at the injection area
Purified Water, Caprylic/Capric Triglyceride, Glycerin, 1,2-Hexanediol, Alpha-Arbutin (2%), Niacinamide (2%), Cetearyl Alcohol, Cetearyl Oliveate, Titanium Dioxide , glutathione (0.15%), hydrolyzed collagen extract, sorbitan olivate, ammonium polyacryloyldimethyltaurate, vinyl dimethicone, glyceryl stearate, polymethylsilsesquioxane, isononylisono Nanoate, t-butyl alcohol, polyhydroxystearic acid, triethoxycaprylylsilane, aluminum hydroxide, ethoxydiglycol, butylene glycol, octyldodecanol, ethylhexylglycerin, Asiaticoside, Hydrogenated Lecithin, Asiatic Acid, Madecassic Acid, Glycolipid, C12-13 Phares-9, Kudzu Root Extract, Giant Pine Leaf Extract, Elm Root Extract, Evening Primrose Extract, Fragrance, Hexylcinnamal , linalool, limonene